Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Number of Prior Biologic Disease-modifying Anti-rheumatic Drugs

被引:0
|
作者
Mease, Philip [1 ]
Lertratanakul, Apinya [2 ]
Strober, Bruce [3 ,4 ]
Tsuji, Shigeyoshi [5 ]
Richette, Pascal [6 ]
Lovan, Charlie [2 ]
Feng, Dai [2 ]
Anderson, Jaclyn K. [2 ]
Van den Bosch, Filip [7 ]
机构
[1] Seattle Rheumatol Associates PLLC, Seattle, WA USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Yale Univ, Sch Med, New Haven, CT USA
[4] Cent Connecticut Dermatol, New Haven, CT USA
[5] Natl Hosp Org, Osaka Minami Med Ctr, Dept Orthopaed Rheumatol, Osaka, Japan
[6] Lariboisiere Hosp, Dept Rheumatol, Paris, France
[7] Ghent Univ Hosp, Ghent, Belgium
关键词
INADEQUATE RESPONSE; DOUBLE-BLIND; SAFETY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1356
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [42] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [43] INFECTIOUS COMPLICATIONS AS A REASON FOR THE CANCELLATION OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    Aronova, E.
    Gridneva, G.
    Kudryavtceva, A.
    Dydykina, I.
    Lukina, G.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S250 - S250
  • [44] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Clélia Monchablon
    Henri Gondé
    Sophie Pouplin
    Rémi Varin
    Olivier Vittecoq
    Thierry Lequerré
    Clinical Rheumatology, 2020, 39 : 207 - 216
  • [45] Efficacy of Disease Modifying Anti-Rheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort
    Mathew, Ashish
    Sutton, Mitchell
    Pereira, Daniel
    Chandran, Vinod
    Gladman, Dafna
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [46] Ovarian Reserve in Children with Juvenile Idiopathic Arthritis Using Biologic Disease-Modifying Anti-Rheumatic Drugs
    Ozer, Yavuz
    Yildiz, Mehmet
    Turan, Hande
    Tarcin, Gurkan
    Aydin, Dilek Bingol
    Gunalp, Aybuke
    Haslak, Fatih
    Konte, Elif Kilic
    Aslan, Esma
    Koker, Oya
    Bayramoglu, Elvan
    Sahin, Sezgin
    Adrovic, Amra
    Barut, Kenan
    Kasapcopur, Ozgur
    Evliyaoglu, Olcay
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 400 - 400
  • [47] Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
    Ozer, Yavuz
    Yildiz, Mehmet
    Turan, Hande
    Tarcin, Gurkan
    Aydin, Dilek Bingol
    Gunalp, Aybuke
    Haslak, Fatih
    Konte, Elif Kilic
    Aslan, Esma
    Koker, Oya
    Bayramoglu, Elvan
    Sahin, Sezgin
    Adrovic, Amra
    Barut, Kenan
    Kasapcopur, Ozgur
    Evliyaoglu, Olcay
    CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 399 - 406
  • [48] Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis
    Whittle, Samuel L.
    Glennon, Vanessa
    Johnston, Renea, V
    Avery, Jodie C.
    Bell, J. Simon
    Brennan, Sue E.
    Fong, Christopher
    Hissaria, Pravin
    Horgan, Ben
    O'Neill, Sean
    Pisaniello, Huai Leng
    Trevena, Lyndal
    Whittaker, Glen A.
    Wluka, Anita
    Buchbinder, Rachelle
    INTERNAL MEDICINE JOURNAL, 2022, 52 (10) : 1799 - 1805
  • [49] PREDICTIVE FACTORS FOR SUCCESSFUL BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS DOSE TAPERING IN RHEUMATOID ARTHRITIS
    Loh, Min Yi
    Jones, Claire J.
    Peall, Adrian
    Trickey, Jeanette
    RHEUMATOLOGY, 2023, 62
  • [50] Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
    Yavuz Ozer
    Mehmet Yildiz
    Hande Turan
    Gurkan Tarcin
    Dilek Bingol Aydin
    Aybuke Gunalp
    Fatih Haslak
    Elif Kilic Konte
    Esma Aslan
    Oya Koker
    Elvan Bayramoglu
    Sezgin Sahin
    Amra Adrovic
    Kenan Barut
    Ozgur Kasapcopur
    Olcay Evliyaoglu
    Clinical Rheumatology, 2024, 43 (1) : 399 - 406